Press ReleasesIrish Citizens’ Assembly On Drugs Use Could Boost Medicinal...

Irish Citizens’ Assembly On Drugs Use Could Boost Medicinal Cannabis

-

PRESS RELEASE

THE Cannabis Industry Council (CIC) has welcomed the establishment of a Citizens’ Assembly on Drugs Use in Ireland, and the appointment of former Health Service Executive CEO, Paul Reid, as its chair.

Peter Reynolds, chair of CIC Ireland, said:

“The Cannabis Industry Council very much hopes this development will unlock the stalemate on drugs policy in Ireland. The current Medical Cannabis Access Programme (MCAP) is one of the most restrictive in Europe. MCAP has completely excluded thousands of Irish people who suffer from chronic pain, the indication for which the medicine is most often prescribed.

“Ireland is also in a really bad place in respect to hemp and CBD. The authorities have been seizing products and prosecuting people, in defiance of EU law. While the courts have handed down seemingly contradictory judgments.

“The sector had previously been booming, creating new businesses and jobs. It does though seem a strong possibility that the Citizens’ Assembly will recommend some form of liberalisation, which could revive the sector and provide a boost to Ireland’s economy.”

The appointment of Paul Reid as chair of the Citizens’ Assembly has been met with some concern as he is strongly associated with the existing ineffective system of drugs policy and treatment.

Peter Reynolds commented:

“Ireland’s medical establishment has been very negative about medicinal cannabis, undermining MCAP, even though it is government policy. Mr Reid will know his way around the system so hopefully he will help to deliver the reform that is desperately needed.

“We will be holding Mr Reid to account to ensure an evidence-based approach, with harm reduction and economic growth at the core, is pursued.”

The Citizens’ Assembly on Drugs Use in Ireland was established by the Irish Government, following resolutions in Dáil and Seanad Éireann in late February.

It will consist of 100 members, including the independent chairperson and 99 members of the general public. The first meeting of the Citizens’ Assembly is scheduled to take place on 14 April.

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Proposed Changes To Germany’s Medical Cannabis Framework Would ‘Seriously Impact Both Patients And Industry’ If Brought In Tomorrow

TOMORROW, Germany’s Federal Joint Committee (G-BA) is expected to announce major changes to the country’s medical cannabis framework.  These could...

Will Twitter’s ‘Relaxation’ On Cannabis Advertising Help Break The Industry’s Social Media Ad Embargo?

TWITTER has become the first major social media platform to openly allow the advertisement of cannabis brands.  Since the new...

Kanabo Launches New Online Medical Cannabis Clinic ‘Treat It’, Offering Access To Doctors In ‘Less Than 24 Hours’

KANABO Group has today announced the launch of a new online medical cannabis clinic for pain management, Treat It.  The...

Must read

You might also likeRELATED
Recommended to you